Chest Pain in Duchenne Muscular Dystrophy (DMD)
Yes, patients with Duchenne muscular dystrophy can experience chest pain, particularly as a manifestation of the cardiomyopathy that develops as part of the disease progression. 1
Cardiac Involvement in DMD
- DMD is an X-linked genetic disorder affecting approximately 1 in 5000 live male births, characterized by progressive loss of muscle function due to mutations in the dystrophin gene 2
- Historically, respiratory failure was the most common cause of death, but with improved respiratory support, cardiomyopathy has become an increasingly important source of morbidity and mortality 2
- Cardiomyopathy in DMD typically presents as a hypokinetic, dilated phenotype that progressively worsens with age 3
Chest Pain Presentation in DMD
- Chest pain with troponin elevation has been documented in DMD patients, indicating acute cardiac events that may represent significant progression of cardiomyopathy 1
- These episodes can present as:
- During these events, patients may show:
Cardiac Manifestations in DMD
- Only about 30% of boys with DMD have cardiac symptoms at the time of cardiomyopathy diagnosis, making it often clinically silent 2
- DMD cardiomyopathy is characterized by:
- Less left ventricular enlargement at diagnosis compared to other forms of dilated cardiomyopathy 2
- Higher mortality rate than other dilated cardiomyopathies 2
- Typical ECG findings including increased R/S ratio in right precordial leads, deep Q waves in lateral leads, conduction abnormalities, and arrhythmias 4
- Subepicardial fibrosis in the inferolateral wall as the typical cardiac MRI lesion 4
Clinical Implications and Management
- Chest pain episodes with troponin elevation may represent an important pathophysiological mechanism in cardiomyopathy progression in DMD patients 1
- This clinical presentation is under-recognized but significant as it may indicate acute left ventricular dysfunction and development or progression of myocardial fibrosis 1
- Regular cardiac care is crucial in DMD management 3
- Early recognition and prophylactic use of angiotensin converting enzyme inhibitors (ACEIs) are the mainstay therapeutic strategy to delay the incidence of DMD cardiomyopathy 3, 4
- Addition of beta-blockers to ACEIs has shown improvement in left ventricular systolic function in muscular dystrophy patients 4
Monitoring Recommendations
- Cardiac MRI is increasingly recommended for surveillance of myocardial damage and function in DMD patients, as it can detect early changes and fibrosis that may not be visible on echocardiography 2
- Tissue Doppler echocardiography can be used to identify early changes of cardiomyopathy and detect progressive cardiac damage 4
- Patients presenting with chest pain should receive comprehensive cardiac evaluation including ECG, troponin measurement, and cardiac imaging 1
In conclusion, chest pain in DMD patients should be taken seriously as it may indicate significant cardiac involvement and progression of cardiomyopathy, which is a leading cause of morbidity and mortality in this population.